Kearns Sayre Syndrome (Kss) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Kearns-Sayre syndrome (KSS) is a rare mitochondrial encephalomyopathy characterized by the classic triad of progressive external ophthalmoplegia, pigmentary retinopathy, and onset before age 20<sup>[1]</sup>. It is one of the mitochondrial DNA deletion syndromes that causes multi-system neurodegeneration with significant morbidity. [^2]
Genetics
KSS follows mitochondrial inheritance and is typically sporadic<sup>[2]</sup>. The condition is caused by: [^3]
Large-scale deletions of mitochondrial DNA (typically 1.1-10 kb)
Multiple mtDNA deletions in autosomal dominant pedigrees
The same 4,977-bp "common deletion" has been identified in KSS and Pearson marrow-pancreas syndrome, with tissue distribution of mutant mtDNA determining the clinical phenotype<sup>[2]</sup>. [^4]
Clinical Features
Core Diagnostic Criteria
KSS requires onset before age 20 with the classic triad: [^5]
...
Kearns-Sayre Syndrome (KSS)
Introduction
Kearns Sayre Syndrome (Kss) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Kearns-Sayre syndrome (KSS) is a rare mitochondrial encephalomyopathy characterized by the classic triad of progressive external ophthalmoplegia, pigmentary retinopathy, and onset before age 20<sup>[1]</sup>. It is one of the mitochondrial DNA deletion syndromes that causes multi-system neurodegeneration with significant morbidity. [^2]
Genetics
KSS follows mitochondrial inheritance and is typically sporadic<sup>[2]</sup>. The condition is caused by: [^3]
Large-scale deletions of mitochondrial DNA (typically 1.1-10 kb)
Multiple mtDNA deletions in autosomal dominant pedigrees
The same 4,977-bp "common deletion" has been identified in KSS and Pearson marrow-pancreas syndrome, with tissue distribution of mutant mtDNA determining the clinical phenotype<sup>[2]</sup>. [^4]
Clinical Features
Core Diagnostic Criteria
KSS requires onset before age 20 with the classic triad: [^5]
Progressive External Ophthalmoplegia (PEO) — progressive weakness of eye muscles
Pigmentary Retinopathy — "salt-and-pepper" retinal degeneration leading to visual field defects
The study of Kearns Sayre Syndrome (Kss) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research (2024-2026)
This section highlights recent publications relevant to this disease.
[Genotype-Phenotype Correlations in Chinese Pediatric Patients With Single Large-Scale Mitochondrial DNA Deletion Disorders.](https://pubmed.ncbi.nlm.nih.gov/41074779/) (2026 Apr) - Clinical genetics
[Outcomes of kidney transplantation in three patients with single large-scale mitochondrial DNA deletion syndromes.](https://pubmed.ncbi.nlm.nih.gov/41610485/) (2026 Mar) - Molecular genetics and metabolism
[Choroidal neovascularization in a teenager with Kearns Sayre syndrome.](https://pubmed.ncbi.nlm.nih.gov/41087305/) (2026 Feb) - Ophthalmic genetics
[CRISPR prime editing of mitochondrial heteroplasmy in rare Kearns-Sayre syndrome: ocular and cardiac synergies.](https://pubmed.ncbi.nlm.nih.gov/41496996/) (2026 Jan) - Annals of medicine and surgery (2012)